Johnson & Johnson - Index

Johnson & Johnson - report - Index

24
2007 YEAR IN REVIEW:
Consumer Health Care
• Building the World’s Premier Consumer Health Care Business
• Pfizer Consumer Healthcare Acquisition Strengthens Segment
Bringing Science to the Art of Beauty ™ :
Acne Control, Anti-Aging and Sun Protection
In 2007, our skin care business addressed the
needs of women worldwide with numerous
new products to treat and prevent acne,
address signs of aging and protect the skin
from harmful UV rays. Many of the product
launches in 2007—from a broad portfolio of
brands that includes CLEAN & CLEAR ®, ROC ®,
NEUTROGENA ®, AVEENO ®, LUBRIDERM ®,
AMBI ® and GROUPE VENDOME ®—were built
on proprietary technology platforms proven
effective through extensive clinical research.
The CLEAN & CLEAR ® ADVANTAGE ®
Acne Control Kit with ACELERA ™ Complex
fights the multiple causes of acne to clear
pimples and prevent new ones from forming.
In studies, 100 percent of
people showed a decrease
in size, redness and number
of pimples in one day.
AVEENO ® expanded
its leadership in ACTIVE
NATURALS ™ with the
launch of the POSITIVELY
AGELESS ™ anti-aging
skin care line, which leverages the benefits
of shiitake mushroom complex to accelerate
skin cell renewal. ROC ® celebrated 50
years of skin care excellence in anti-aging
products with the launch of RETINOL
CORREXION ® HAND REPAIR with SPF 15 and
Daily Microdermabrasion Cleansing Disks.
Neutrogena expanded its offering of
innovative at-home cleansing and exfoliation
systems with the NEUTROGENA WAVE ™
Power-Cleanser and Deep Clean Foaming
Pads, and the Healthy Skin Rejuvenator,
which improves firmness and the appearance
of fine lines, wrinkles and age spots. The
NEUTROGENA ® Anti-Oxidant Age Reverse
line includes ESSENTIAL SOY ™, an ingredient
proven to improve skin texture and
tone, as well as reduce the appearance of
discoloration. This line also provides broadspectrum
protection from damaging UVA and
UVB rays through HELIOPLEX ™, our patented
sunscreen technology platform, which is also
known as ACTIVE PHOTOBARRIER COMPLEX ™
in the AVEENO ® CONTINUOUS PROTECTION ™
line of lotions and sprays.
Integration of
Pfizer Consumer
Healthcare
On Track
In December 2006,
Johnson & Johnson
completed the largest
transaction in its history,
acquiring the Pfizer
Consumer Healthcare
(PCH) business for $16.6
billion. Throughout 2007,
the Consumer Group
successfully integrated
thousands of employees and
hundreds of brands from
PCH while continuing to
grow its businesses.
In the months following
the approval of the PCH
acquisition by U.S. and
European regulators, the
transaction was officially
closed under the laws of
112 countries. In each
of these countries, new
employees received an
orientation that included
education about the history
and meaning of the
Johnson & Johnson Credo.
Thousands of newly acquired
products were properly
registered with regulatory
authorities around the world.
Actions were taken to re-site
manufacturing operations,
consolidate facilities,
transfer information
technology systems and
relabel products. All this
carefully orchestrated
activity took place—and in
many cases continues—with
virtually no disruption to
day-to-day business.
J O H N S O N & J O H N S O N 2 0 0 7 A N N U A L R E P O R T